914
Views
13
CrossRef citations to date
0
Altmetric
BASIC REVIEW

COPD—The Primary Care Perspective: Addressing Epidemiology, Pathology, Diagnosis, Treatment of Smoking's Multiple Morbidities and the Patient's Perspective

&
Pages 67-83 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mousa Al Omari, Basheer Y Khassawneh, Yousef Khader, Ali Shakir Dauod & George Bergus. (2014) Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 753-758.
Read now
Barbara P Yawn, Peter Wollan & Matthew Rank. (2013) Exacerbations in the pre- and post-COPD diagnosis periods. Pragmatic and Observational Research 4, pages 1-6.
Read now
Barbara P Yawn, Ibrahim Raphiou, Judith S Hurley & Anand A Dalal. (2010) The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 165-178.
Read now

Articles from other publishers (10)

V. K. Zafiraki, E. D. Kosmacheva, S. G. Mirzaev, L. V. Shulzhenko, J. M. Ramazanov, A. A. Omarov, Zh. B. Imetova & I. V. Pershukov. (2021) Chronic obstructive pulmonary disease in patients with coronary heart disease worsens long-term prognosis after percutaneous coronary interventions. Kardiologiia 61:11, pages 24-32.
Crossref
Guangan Hu, Ting Dong, Sisi Wang, Hongyu Jing & Jianzhu Chen. (2019) Vitamin D3-vitamin D receptor axis suppresses pulmonary emphysema by maintaining alveolar macrophage homeostasis and function. EBioMedicine 45, pages 563-577.
Crossref
RE Goldman, L Mennillo, P Stebbins & DR Parker. (2016) How do patients conceptualize chronic obstructive pulmonary disease?. Chronic Respiratory Disease 14:3, pages 245-255.
Crossref
Jordi Olloquequi & Rafael Silva O. (2016) Biomass smoke as a risk factor for chronic obstructive pulmonary disease: effects on innate immunity. Innate Immunity 22:5, pages 373-381.
Crossref
Anthony D D'Urzo, M Reza Maleki-Yazdi & R Andrew McIvor. (2014) Evolving therapies in chronic obstructive pulmonary disease. Clinical Practice 11:3, pages 307-325.
Crossref
Barbara J. Zarowitz, Terrence O’Shea, Allen Lefkovitz & Edward L. Peterson. (2011) Development and Validation of a Screening Tool for Chronic Obstructive Pulmonary Disease in Nursing Home Residents. Journal of the American Medical Directors Association 12:9, pages 668-674.
Crossref
Barbara Yawn. (2011) Translating guidelines into community practice: signs and symptoms are not enough. Primary Care Respiratory Journal 20:2, pages 111-112.
Crossref
. (2012) Antwoorden. Tijdschrift voor praktijkondersteuning 6:1, pages 27-27.
Crossref
Yannick M.T.A. van Durme, Katia M.C. Verhamme, Theo Stijnen, Frank J.A. van Rooij, Geert R. Van Pottelberge, Albert Hofman, Guy F. Joos, Bruno H.Ch. Stricker & Guy G. Brusselle. (2009) Prevalence, Incidence, and Lifetime Risk for the Development of COPD in the Elderly. Chest 135:2, pages 368-377.
Crossref
Antonello Punturieri, Thomas L. Croxton, Gail G. Weinmann & James P. Kiley. (2008) Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 178:5, pages 441-443.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.